We quantitatively determined the synthesis of specific antibodies in a patient with chikungunya disease by antibody index (AI) as described by Reiber and Felgenhauer (6).The antibody index discriminates the pathologic fraction of specific brain-derived CSF
immunoglobulin, considering the transfer of blood proteins into CSF. It is based on the analysis of specific antibodies in paired serum and CSF by ELISA technique, and the blood-CSF barrier function (Qalb). We used the Panbio Dengue Indirect IgG ELISA kit (Panbio, Brisbane, Australia) and the Anti-Chikungunya virus (IgG) ELISA kit (EUROIMMUN, Luebeck, Germany). We calculated the antibody index (AI = Q spec/Q IgG) with the ratio between the specific IgG and total IgG, considering that there was no intrathecal synthesis of total IgG (IgGIF <0%). We established a reference curve of 0.05-2.0 absorbance units on the basis of serial dilution of the manufacturer´s positive control. We defined the maximum value of absorbance as 100 arbitrary concentration units. The sample dilutions for dengue virus were 1:8 for CSF and 1:4000 for serum; for CHIKV, 1:2 for CSF and 1:101 for serum (6-8). days after acute infection with chikungunya virus, Rio de Janeiro, Brazil.
